Gloria S Huang

Summary

Affiliation: Albert Einstein College of Medicine
Country: USA

Publications

  1. pmc Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center Bronx, NY, USA
    Am J Obstet Gynecol 203:242.e1-5. 2010
  2. pmc Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer
    Gloria S Huang
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Clin Cancer Res 16:2999-3010. 2010
  3. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:26-30. 2012
  4. pmc Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma
    Gloria S Huang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Am J Obstet Gynecol 200:457.e1-5. 2009
  5. doi request reprint A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
    Divya Gupta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 113:327-30. 2009
  6. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:21-5. 2012
  7. doi request reprint Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma
    Divya Gupta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY 10065, USA
    Int J Gynecol Cancer 21:529-34. 2011
  8. pmc Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Gynecol Oncol 107:513-7. 2007
  9. pmc Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer
    Elizabeth R Burton
    Department of Surgery, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461, USA
    Mol Cancer Res 9:1126-38. 2011
  10. ncbi request reprint Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Am J Obstet Gynecol 196:243.e1-5. 2007

Collaborators

Detail Information

Publications15

  1. pmc Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center Bronx, NY, USA
    Am J Obstet Gynecol 203:242.e1-5. 2010
    ..We sought to evaluate the expression of G protein-coupled receptor 30 (GPR30) and estrogen receptor (ER)beta in uterine carcinosarcoma (CS)...
  2. pmc Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer
    Gloria S Huang
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Clin Cancer Res 16:2999-3010. 2010
    ..This study was undertaken to examine the role of the insulin-like growth factor (IGF) signaling pathway in the response of ovarian cancer cells to Taxol and to evaluate the significance of this pathway in human epithelial ovarian tumors...
  3. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:26-30. 2012
    ..This is the first report describing the efficacy and toxicity of adjuvant ifosfamide or ifosfamide plus cisplatin "sandwiched" with RT in patients with surgically staged and completely resected uterine carcinosarcoma...
  4. pmc Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma
    Gloria S Huang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Am J Obstet Gynecol 200:457.e1-5. 2009
    ....
  5. doi request reprint A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
    Divya Gupta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 113:327-30. 2009
    ..A phase II trial designed to evaluate the safety and efficacy of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine or epithelial ovarian cancers...
  6. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:21-5. 2012
    ..To evaluate the safety and survival in women treated with adjuvant pelvic radiation "sandwiched" between six cycles of paclitaxel and carboplatin chemotherapy with completely resected UPSC...
  7. doi request reprint Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma
    Divya Gupta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY 10065, USA
    Int J Gynecol Cancer 21:529-34. 2011
    ..Serum CA125 is a potential biomarker for metastatic disease and recurrence in patients with uterine papillary serous carcinoma (UPSC)...
  8. pmc Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Gynecol Oncol 107:513-7. 2007
    ..The purpose of this study was to determine the clinical utility of CA125 measurement in patients with uterine carcinosarcoma (CS)...
  9. pmc Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer
    Elizabeth R Burton
    Department of Surgery, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461, USA
    Mol Cancer Res 9:1126-38. 2011
    ....
  10. ncbi request reprint Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Am J Obstet Gynecol 196:243.e1-5. 2007
    ..This study was undertaken to evaluate the ability of preoperative endometrial sampling to accurately diagnose high-grade endometrial tumors...
  11. ncbi request reprint Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice
    Gloria S Huang
    Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Clin Cancer Res 12:298-304. 2006
    ..To evaluate the drug combination of discodermolide and Taxol in human ovarian cancer cells and in an in vivo model of ovarian carcinoma...
  12. doi request reprint Extragenital adenosarcoma: a case report, review of the literature, and management discussion
    Gloria S Huang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Albert Einstein Cancer Center, 1695 Eastchester Road, Suite 601, Bronx, NY 10461, USA
    Gynecol Oncol 115:472-5. 2009
    ..Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior...
  13. ncbi request reprint Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer
    Jurriaan Brouwer-Visser
    Department of Obstetrics and Gynecology and Women s Health Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
    PLoS ONE 9:e100165. 2014
    ..These findings validate IGF2 as a potential therapeutic target in drug resistant ovarian cancer and show that directly targeting IGF2 may be a preferable strategy compared with targeting IGF1R alone. ..
  14. ncbi request reprint Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Bronx, New York, USA
    Cancer 109:48-53. 2007
    ..This study was designed to test for differences in progression-free survival (PFS) and toxicity between the 2 regimens...
  15. ncbi request reprint Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinoma
    Gloria S Huang
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Stanford, CA 94303, USA
    Gynecol Oncol 87:313-8. 2002
    ..Primaryadenocarcinoma of the vulva is a rare entity, and for widely metastatic vulvar adenocarcinoma, no effective treatment has been established...